Condition: Plantar Fascitis · Heel Pain · Musculoskeletal Diseases · Sponsor: CrannMed
This is a prospective, single center, double arm, randomized, unmasked, First in Human study that aims to evaluate the safety and effectiveness of SakuraBead™ resorbable embolization microspheres in adult patients suffering from pain secondary to plantar fasciitis.
This description comes directly from the study's public registry record.
Chief Operations Officer · +1 800 353 4246 · joan.mccabe@crannmed.com
Always discuss trial participation with your own doctor first.
| Nano Medical Clinic | Tashkent, Uzbekistan, Uzbekistan | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07241884